Henderson Jane sold APGE
September 3, 2026 · Form 4 insider transaction
Henderson Jane sold 175,345 shares of Apogee Therapeutics, Inc., a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
175,345
Price
N/A
Total value
N/A
InsiderHenderson Jane
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeD: Disposition to the issuer
Transaction dateSeptember 3, 2026
Filing dateSeptember 3, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each reported option was disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the per share merger consideration of $135.11 over the exercise price of such option.; The reported options were vested as of the date of the Merger or became fully vested in connection with the Merger.